Back to Search
Start Over
Utility of FDG-PET for investigating unexplained serum AFP elevation in patients with suspected hepatocellular carcinoma recurrence.
- Source :
-
Anticancer research [Anticancer Res] 2005 Nov-Dec; Vol. 25 (6C), pp. 4719-25. - Publication Year :
- 2005
-
Abstract
- Unlabelled: The aim of this study was to evaluate the potential role of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with unexplained rising serum alpha-fetoprotein (AFP) levels after the treatment of hepatocellular carcinoma (HCC).<br />Patients and Methods: Thirty-one FDG-PET studies were performed in 26 patients (age range, 45-83; 21 men and 5 women), who had undergone either surgical resection or interventional therapy for HCC, but were subsequently noted to have high AFP serum levels on routine follow-up examinations, although imaging studies and physical examinations were normal. The FDG-PET results were correlated with histological findings, as well as long-term radiological and clinical follow-up (shortest follow-up period after FDG-PET was 6 months).<br />Results: FDG-PET was abnormal in 22 of the 31 studies (71.0%) among the 26 patients. Intrahepatic lesions were detected in 20 of a total 30 lesions (66.7%) in 18 studies of FDG-PET among 26 patients. Ten FDG-PET studies among 9 patients identified one intrahepatic lesion, while 3 studies among 3 patients identified more than one intrahepatic lesion. Extrahepatic metastases were found in 9/31 studies of FDG-PET (29.0%) among 8 patients. These metastatic foci, composed of increased FDG accumulation, were identified in several locations; lung (4 studies among 4 patients), bone (2 studies among 2 patients) and the peritoneum (4 studies among 3 patients). Overall, FDG-PET for detecting HCC recurrence demonstrated 22 true-positives, 8 false-negatives, 1 true-negative and 0 false-positive results., The sensitivity, specificity and accuracy of FDG-PET for detecting HCC recurrence was 73.3%, 100% and 74.2%, respectively.<br />Conclusion: When conventional examinations are normal, FDG-PET is a valuable imaging tool in patients who have rising AFP levels after HCC treatment. FDG-PET whole-body scan also provides an important and valuable imaging study for detecting extrahepatic metastasis.
- Subjects :
- Adult
Aged
Aged, 80 and over
Carcinoma, Hepatocellular pathology
Carcinoma, Hepatocellular therapy
Female
Humans
Liver Neoplasms pathology
Liver Neoplasms therapy
Male
Middle Aged
Neoplasm Recurrence, Local blood
Neoplasm Recurrence, Local diagnostic imaging
Positron-Emission Tomography
Retrospective Studies
Carcinoma, Hepatocellular blood
Carcinoma, Hepatocellular diagnostic imaging
Fluorodeoxyglucose F18 pharmacokinetics
Liver Neoplasms blood
Liver Neoplasms diagnostic imaging
Radiopharmaceuticals pharmacokinetics
alpha-Fetoproteins metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0250-7005
- Volume :
- 25
- Issue :
- 6C
- Database :
- MEDLINE
- Journal :
- Anticancer research
- Publication Type :
- Academic Journal
- Accession number :
- 16334166